Featured Articles

1. RFK Jr. Wants Every American Wearing A Wearable. How Can Pharma Build A Business Around It? 9/16/2025

   The timing is now for pharma to be all-in on using wearables as their new business strategy, says Digital Medicine Society (DiMe) Director of Partnerships Smit Patel, PharmD.

2. The Death Of A Dogma: David Baltimore And Lessons For Modern Drug Discovery 9/11/2025

   Nobel laureate, David Baltimore passed away at 87 years old, on September 6, 2025. He was widely regarded as a scientific visionary who at just 37, co-discovered reverse transcriptase, an enzyme that flipped molecular biology on its head by showing that genetic information could flow from RNA back to DNA, not just the other way around. 

3. How Biotech Leaders Keep Pace With The Next Wave Of Genetic Therapies 9/11/2025

   Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop tomorrow's genetic therapies.

4. The New FDA Era Of Radical Transparency And Pervasive Oversight 9/9/2025

   The first half of 2025 has been transformative for biopharmaceutical quality and regulatory affairs, with the FDA leading the charge with four significant changes. Curadian Group's David Grote discusses implications for all four.

5. Ten Years Of FAIR: How Far We've Come, And How Far We Still Need To Go 9/4/2025

   Life sciences organizations face challenges spanning culture, leadership, infrastructure, and skills to implement FAIR data principles, but progress is being made, writes Giovanni Nisato, Ph.D.

6. N=1: Redefining Clinical Pathways for Ultra-Rare Disease Treatment 9/1/2025

   The N=1 frontier isn't just about helping the rarest patients, it's about building the infrastructure for medicine's future, write experts at Uncommon Cures.

7. RWE Is Not Optional, It's Essential 8/25/2025

   UCB Head of Medical Strategy, Bone Health, Jennifer Timoshanko explains why RWE is a valuable alternative to RCTs and shares best practices for collecting it.

8. Vegas To Tokyo: How Global Tech Conferences Shape Healthcare's Future 8/19/2025

   Google's Shweta Maniar writes about what she's learned traveling to conferences across the planet to talk about the convergence of healthcare, drug development, and digital technology.

9. The Future Of Psychedelic-Inspired Therapeutics: No-Trip Neuroplastogens 8/14/2025

   Non-hallucinogenic neuroplastogens offer benefits over classical psychedelics, including simpler delivery, stronger IP protection, and patient tolerability, writes Enveric Biosciences CEO Joseph Tucker, Ph.D.

10. Staying Ahead In A Rapidly Evolving Obesity Market 8/11/2025

    As new therapies for obesity enter the market, biopharmaceutical companies will need to tune commercial strategies to win market share in an increasingly crowded therapeutic area.